Giacomo Forti

1.4k total citations
12 papers, 288 citations indexed

About

Giacomo Forti is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Giacomo Forti has authored 12 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Genetics and 3 papers in Surgery. Recurrent topics in Giacomo Forti's work include Microscopic Colitis (7 papers), Inflammatory Bowel Disease (7 papers) and Biosimilars and Bioanalytical Methods (2 papers). Giacomo Forti is often cited by papers focused on Microscopic Colitis (7 papers), Inflammatory Bowel Disease (7 papers) and Biosimilars and Bioanalytical Methods (2 papers). Giacomo Forti collaborates with scholars based in Italy. Giacomo Forti's co-authors include Antonio Tursi, Giovanni Brandimarte, Gian Marco Giorgetti, Maria Ester Modeo, Antônio Penna, Marcello Picchio, Walter Elisei, Roberto Faggiani, Costantino Zampaletta and GianMarco Giorgetti and has published in prestigious journals such as Gastroenterology, Digestion and European Journal of Internal Medicine.

In The Last Decade

Giacomo Forti

12 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giacomo Forti Italy 8 176 123 103 91 69 12 288
M. Russel Netherlands 4 236 1.3× 110 0.9× 184 1.8× 109 1.2× 98 1.4× 9 386
Erik Rahimi United States 7 77 0.4× 158 1.3× 73 0.7× 79 0.9× 142 2.1× 33 417
C. Amadini Italy 8 174 1.0× 112 0.9× 81 0.8× 121 1.3× 103 1.5× 11 330
Keiichiro Saigusa Japan 7 151 0.9× 158 1.3× 125 1.2× 21 0.2× 69 1.0× 8 336
Tytti Jaakkola Finland 6 170 1.0× 290 2.4× 131 1.3× 31 0.3× 75 1.1× 8 454
S Giaccari Italy 5 177 1.0× 106 0.9× 106 1.0× 29 0.3× 117 1.7× 5 342
Antônio Penna Italy 11 93 0.5× 56 0.5× 83 0.8× 38 0.4× 79 1.1× 22 269
Franziska Durchschein Austria 7 72 0.4× 129 1.0× 166 1.6× 41 0.5× 86 1.2× 17 376
Daniela Elena Serban Romania 9 134 0.8× 131 1.1× 99 1.0× 75 0.8× 84 1.2× 22 353
Ofer Ben‐Bassat Israel 10 221 1.3× 61 0.5× 170 1.7× 23 0.3× 86 1.2× 22 312

Countries citing papers authored by Giacomo Forti

Since Specialization
Citations

This map shows the geographic impact of Giacomo Forti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giacomo Forti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giacomo Forti more than expected).

Fields of papers citing papers by Giacomo Forti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giacomo Forti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giacomo Forti. The network helps show where Giacomo Forti may publish in the future.

Co-authorship network of co-authors of Giacomo Forti

This figure shows the co-authorship network connecting the top 25 collaborators of Giacomo Forti. A scholar is included among the top collaborators of Giacomo Forti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giacomo Forti. Giacomo Forti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Tursi, Antonio, Leonardo Allegretta, Nicola Della Valle, et al.. (2017). Effectiveness and safety of infliximab biosimilar CT-P13 in treating ulcerative colitis: a real‑life experience in IBD primary centers. Minerva Gastroenterology. 63(4). 313–318. 12 indexed citations
2.
Tursi, Antonio, Leonardo Allegretta, Nicola Della Valle, et al.. (2017). Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers. Journal of Gastrointestinal and Liver Diseases. 26(3). 239–244. 21 indexed citations
3.
Tursi, Antonio, Giovanni Brandimarte, Francesco Di Mario, et al.. (2015). Su1349 Predictive Value of the “DICA” Endoscopic Classification on the Outcome of the Diverticular Disease of the Colon. Gastroenterology. 148(4). S–482. 1 indexed citations
4.
Tursi, Antonio, Walter Elisei, Marcello Picchio, et al.. (2014). Histological inflammation in ulcerative colitis in deep remission under treatment with infliximab. Clinics and Research in Hepatology and Gastroenterology. 39(1). 107–113. 14 indexed citations
5.
Tursi, Antonio, Walter Elisei, Marcello Picchio, et al.. (2014). Effectiveness and safety of infliximab and adalimumab for ambulatory Crohn's disease patients in primary gastroenterology centres. European Journal of Internal Medicine. 25(5). 485–490. 15 indexed citations
6.
Tursi, Antonio, Walter Elisei, Marcello Picchio, et al.. (2014). Managing ambulatory ulcerative colitis patients with infliximab: A long-term follow-up study in primary gastroenterology centers. European Journal of Internal Medicine. 25(8). 757–761. 11 indexed citations
7.
Tursi, Antonio, Walter Elisei, Marcello Picchio, et al.. (2014). Effectiveness of adalimumab for ambulatory ulcerative colitis patients after failure of infliximab treatment: a first "real-life" experience in primary gastroenterology centers in Italy.. PubMed. 27(4). 369–373. 13 indexed citations
8.
Tursi, Antonio, Giovanni Brandimarte, Alfredo Papa, et al.. (2009). 388 Supplementation with the Probiotic VSL#3 in Patients with Mild-to-Moderate Active Ulcerative Colitis: A Double-Blind, Randomized, Placebo-Controlled Study. Gastroenterology. 136(5). A–64. 2 indexed citations
9.
Corona, Giovanni, Luisa Petrone, Edoardo Mannucci, et al.. (2006). Psycho-biological correlates of smoking in patients with erectile dysfunction. Università Politecnica delle Marche (Università Politecnica delle Marche). 2 indexed citations
10.
Tursi, Antonio, et al.. (2004). Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis.. PubMed. 10(11). PI126–31. 173 indexed citations
11.
Schiavino, Domenico, et al.. (1992). [Mucocutaneous lichen planus with esophageal involvement. A clinical case].. PubMed. 83(1-2). 73–6. 3 indexed citations
12.
Geñtilini, Paolo, Giacomo Laffi, G Buzzelli, et al.. (1980). Functional Renal Alterations in Chronic Liver Diseases. Digestion. 20(2). 73–78. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Russel Breakdown of academic impact, for papers by Erik Rahimi Breakdown of academic impact, for papers by C. Amadini Breakdown of academic impact, for papers by Keiichiro Saigusa Breakdown of academic impact, for papers by Tytti Jaakkola Breakdown of academic impact, for papers by S Giaccari Breakdown of academic impact, for papers by Antônio Penna Breakdown of academic impact, for papers by Franziska Durchschein Breakdown of academic impact, for papers by Daniela Elena Serban Breakdown of academic impact, for papers by Ofer Ben‐Bassat
Rankless by CCL
2026